Related Experiment Video
Updated: May 24, 2026

Robotic Duodenal Sleeve Resection for Gastrointestinal Stromal Tumor with Rare Exon 8 KIT Mutation Following Neoadjuvant Imatinib
Published on: April 3, 2026
Inflammatory myofibroblastic tumour of the duodenum
1Tan Tock Seng Hospital, 11 Jalan Tan Tock Seng, Singapore. fongss@gmail.com
Rare inflammatory myofibroblastic tumours (IMTs) of the duodenum and pancreas mimic cancer. Surgical resection is the primary treatment, offering a curative outcome for these uncommon gastrointestinal stromal tumours.
Area of Science:
- Gastroenterology
- Surgical Oncology
- Pathology
Background:
- Inflammatory myofibroblastic tumours (IMTs) are rare neoplasms with probable immunological origins.
- IMTs in the duodenum and pancreatic head are exceptionally uncommon and often misdiagnosed preoperatively as adenocarcinoma.
- Distinguishing IMTs from pancreatic cancer is crucial for appropriate management.
Observation:
- A case of duodenal IMT causing gastric outlet obstruction is presented.
- Literature review of pancreatic head and duodenal IMTs reveals distinct clinical presentations.
- Pancreatic head IMTs typically manifest as obstructive jaundice, while duodenal IMTs present with gastric outlet obstruction.
Findings:
- Surgical excision is the definitive treatment for both pancreatic head and duodenal IMTs.
- Adjuvant therapies like chemotherapy and radiotherapy are reserved for specific cases, such as incomplete resections or aggressive tumour histology.
- Recurrence rates are low following complete surgical removal, indicating a favorable prognosis.
Implications:
- Accurate preoperative diagnosis of IMTs is essential to avoid aggressive treatment for benign conditions.
- Surgical management provides a curative option for patients with IMTs of the duodenum and pancreas.
- Further research into the aetiology and optimal adjuvant treatment strategies for aggressive IMTs is warranted.
Related Concept Videos
Inflammatory Bowel Disease I: Introduction
Inflammatory Bowel Disease II: Ulcerative Colitis
Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by transmural...
Inflammatory Bowel Disease III: Crohn's Disease
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Chronic Bowel Disorders: Introduction
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
